alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1

Certification Pursuant to Rule 13a-14(b) or Rule 15d-14(b)

of the Securities Exchange Act of 1934
and 18 U.S.C. Section 1350

I, Vicente Anido, Jr., Ph.D., hereby certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange
Act of 1934 and 18 U.S.C. Section 1350, that the Quarterly Report of ISTA Pharmaceuticals, Inc. on Form 10-Q for the quarterly period ended March 31, 2008 fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2008 fairly presents in all material respects the financial condition and results of operations of ISTA
Pharmaceuticals, Inc.



|                  |  |  |  |                                      
|----------------- |  |  |  | -------------------------------------
|                  |  | 
|Date: May 1, 2008 |  |  |  | /s/ Vicente Anido, Jr., Ph.D.        
|                  |  |  |  | Vicente Anido, Jr., Ph.D.            
|                  |  |  |  | President and Chief Executive Officer

This certification accompanies the Quarterly Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the
Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.
STATE v. ROSARIO.

No. COA07-401.

Court of Appeals of North Carolina.

Filed December 4, 2007.

Certification Date December 27, 2007.

Appeal from Buncombe (05CRS9564, 05CRS58306).

Case reported without published opinion. Remanded for resentencing.
IN THE SUPREME COURT OF THE STATE OF DELAWARE 

JAMES PLACHES, 

Defendant Below, 

Appellant, 

v. 

STATE OF DELAWARE, 

Plaintiff Below, 

Appellee. 

§ 

§ No. 165, 2014 

§ 

§ 

§ 

§ Court Below—Superior Court 

§ of the State of Delaware, 

§ in and for Sussex County 

§ Cr. ID 0912004522 

§ 

§ 

 Submitted: September 15, 2014 

 Decided: September 30, 2014 

O R D E R

This 30th day of September 2014, it appears to the Court that, on September 

15, 2014, the Clerk issued a notice to appellant to show cause why this appeal 

should not be dismissed for his failure to diligently prosecute the appeal by not 

filing his opening brief and appendix in this matter. The appellant has failed to 

respond to the notice to show cause within the required ten-day period; therefore, 

dismissal of this action is deemed to be unopposed.

NOW, THEREFORE, IT IS HEREBY ORDERED, pursuant to Supreme 

Court Rules 3(b) and 29(b), that the within appeal is DISMISSED. 

BY THE COURT: 

/s/ Henry duPont Ridgely

Justice
Exhibit 10.46



AMENDMENT 2007-1

TO THE

NOVADEL PHARMA INC.

2006 EQUITY INCENTIVE PLAN



WHEREAS, NovaDel Pharma Inc. (the Company) maintains the NovaDel Pharma Inc. 2006 Equity Incentive Plan (the Plan) for the benefit of its and its affiliates qualifying Employees, Directors and Consultants (as defined in the Plan);

WHEREAS, pursuant to Section 26 of the Plan, the Committee of the Board of Directors of the Company (the Committee) may amend the Plan at any time.

NOW, THEREFORE, in accordance with the foregoing, effective March 2, 2007, the Plan shall be amended as follows:

1.
        Section 4(a) shall be amended and restated as follows:


(a)        The Plan shall be administered by a Committee, which shall consist of two or more members of the Board, all of whom shall qualify as outside directors as defined for purposes of the regulations under Section 162(m) of the Code and as non-employee directors under Rule 16b-3(b)(3)(i) under the 1934 Act. The number of members of the Committee shall from time to time be increased or decreased, and shall be subject to such conditions, in each case as the Board deems appropriate to permit transactions in Shares pursuant to the Plan to satisfy the conditions of Rule 16b-3 and Section 162(m) of the Code as then in effect. The Committee, in its sole discretion, shall have the right to delegate all or any part of its authority under the Plan to a sub-committee comprised of no less than two members of
the Board. In addition, the Committee, in its sole discretion, shall have the right to delegate all or any part of its authority under the Plan for grants to non-officer employees to the chief executive officer of the Company with limitations established by the Committee. In no event, however, will the chief executive officer be authorized to make option grants to any executive officer or member of the Board.

2.
        In all respects not amended, the Plan is hereby ratified and confirmed.




[SIGNATURE PAGE FOLLOWS]



1-PR/1338261.1



---



IN WITNESS WHEREOF, to record the adoption of this Amendment 2007-1 to the Plan, the Company has caused the execution of this instrument, substantially in the form as set forth herein, on this 2nd day of March, 2007.





Attest:
        
        NOVADEL PHARMA INC./s/MICHAEL E. SPICER
        
        By:
        /s/JAN H. EGBERTSMichael E. Spicer
        
        
        Jan H. EgbertsChief Financial Officer and Corporate Secretary
        
        
        President and Chief Executive Officer






1-PR/1338261.1
# Commission Implementing Regulation (EU) No 26/2014Show full title

Commission Implementing Regulation (EU) No 26/2014 of 13 January 2014 establishing the standard import values for determining            the entry price of certain fruit and vegetables         

        - Previous
        - Next

U.K.

# Commission Implementing Regulation (EU) No 26/2014                     

# of 13 January 2014

# establishing the standard import values for determining the entry price of certain fruit and vegetables

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EC) No 1234/2007 of 22 October 2007 establishing a common organisation of agricultural                           markets and on specific provisions for certain agricultural products (Single CMO Regulation)(1),                        

Having regard to Commission Implementing Regulation (EU) No 543/2011 of 7 June 2011 laying down detailed rules for the application                           of Council Regulation (EC) No 1234/2007 in respect of the fruit and vegetables and processed fruit and vegetables sectors(2), and in particular Article 136(1) thereof,                        

Whereas:

(1)Implementing Regulation (EU) No 543/2011 lays down, pursuant to the outcome of the Uruguay Round multilateral trade negotiations,                              the criteria whereby the Commission fixes the standard values for imports from third countries, in respect of the products                              and periods stipulated in Annex XVI, Part A thereto.

(2)The standard import value is calculated each working day, in accordance with Article 136(1) of Implementing Regulation (EU)                              No 543/2011, taking into account variable daily data. Therefore this Regulation should enter into force on the day of its                              publication in the *Official Journal of the European Union*,

HAS ADOPTED THIS REGULATION:

# Article 1U.K.

The standard import values referred to in Article 136 of Implementing Regulation (EU) No 543/2011 are fixed in the Annex to                     this Regulation.                  

# Article 2U.K.

This Regulation shall enter into force on the day of its publication in the *Official Journal of the European Union*.                  

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 13 January 2014.

*For the Commission, On behalf of the President,*                            

Jerzy Plewa                            

*Director-General for Agriculture and Rural Development*                            

## ANNEXU.K.Standard import values for determining the entry price of certain fruit and vegetables

1

OJ L 299, 16.11.2007, p. 1.                           

2

OJ L 157, 15.6.2011, p. 1.
BLEVINS v. TOWN OF WEST JEFFERSON.

No. COA06-930-2.

Court of Appeals of North Carolina.

Filed December 18, 2007.

Certification Date January 7, 2008.

Appeal from Ashe (05CVS515).

Decision without published opinion. Affirmed.
JAMES v. CAROLINA POWER AND LIGHT.

No. COA07-625.

Court of Appeals of North Carolina.

Filed March 4, 2008.

Certification Date March 24, 2008.

Appeal from NC Industrial Commission (I.C. NO. 985521).

Case reported without published opinion. Dismissed.
Exhibit
31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

I, Bradley S. Powell,
Chief Financial Officer of Eden Bioscience Corporation, certify that:

1.     I
have reviewed this quarterly report on Form 10-Q of Eden Bioscience
Corporation;

2.     Based
on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this quarterly
report;

3.     Based
on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this quarterly report;

4.     The
registrants other certifying officer and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)     Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared;

b)     Evaluated
the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and

c)     Disclosed
in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter that
has materially affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting; and

5.     The
registrants other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of the registrants board of
directors (or persons performing the equivalent function):

a)     all
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the registrants ability to record, process, summarize and
report financial information; and

b)     any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial
reporting.

Date:  November
8, 2004

| | /s/ Bradley S. Powell                     
| | ------------------------------------------
| |                                           
| | Bradley S. Powell                         
| | Vice President of Finance, Chief Financial
| | Officer and Secretary                     

- 27 -

---

---
EX-4.1



 Exhibit 4.1 
  






 
 Number 
Protagonist
Therapeutics 
Protagonist Therapeutics, Inc. 
INCORPORATED UNDER THE LAWS OF
THE STATE OF DELAWARE 
Shares 
CUSIP 74366E 10 2 
SEE REVERSE FOR CERTAIN DEFINITIONS 
THIS CERTIFIES THAT 
SPECIMEN 
is the owner of 
FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK, $0.00001 PAR VALUE PER SHARE, OF

PROTAGONIST THERAPEUTICS, INC. 
transferable on the books of the Corporation
in person or by its duly authorized attorney upon surrender of this Certificate properly endorsed. This Certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar. 
Witness the facsimile seal of the Corporation and the facsimile signatures of its duly authorized officers. 
DATED 
PRESIDENT AND CHIEF EXECUTIVE OFFICER 
Protagonist Therapeutics, Inc. 
CORPORATE 
SEAL 
DELAWARE 
CHIEF FINANCIAL OFFICER 
COUNTERSIGNED AND REGISTERED: 
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC 
(Brooklyn, NY) TRANSFER AGENT AND REGISTRAR

BY: 
AUTHORIZED SIGNATURE 
SECURITY-COLUMBIAN UNITED STATES BANKNOTE CORPORATION 







 The following abbreviations, when used in the inscription on the face of this certificate, shall
be construed as though they were written out in full according to applicable laws or regulations: 
  

					
	        TEN COM	 	– as tenants in common	 	UNIF GIFT MIN ACT–                     Custodian
                    
	        TEN ENT	 	– as tenants by the entireties	 	                                      
      (Cust)                          (Minor)
	        JT TEN	 	 – as joint tenants with right of

   survivorship and not as tenants
    in
common
	 	                                      
  under Uniform Gifts to Minors
		 	 	                                      
  Act
                                        

		 	 	                                      
                      (State)

 Additional abbreviations may also be used though not in the above list. 

FOR VALUE RECEIVED,
                                        
HEREBY SELLS, ASSIGNS AND TRANSFERS UNTO 
  

			
	 PLEASE INSERT SOCIAL SECURITY OR OTHER

IDENTIFYING NUMBER OF ASSIGNEE
  
	 	
	      

     
	 	 

  
  

 
 (PLEASE PRINT OR TYPEWRITE NAME AND
ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE) 
  
  

 
  
  

 
  

			
	  
	 	shares

 of Common Stock of the Corporation represented by this Certificate and does hereby irrevocably constitute and appoint 

 

					
	  
	 	 	attorney	  

 to transfer the said shares of Common Stock on the books of the Corporation, with full power of substitution in the premises.

  

			
	Dated	 	  


  

			
	X	 	  

		
	X	 	  

		 	NOTICE: THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME(S) AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER.


  

	
	SIGNATURE(S) GUARANTEED:
	
	  

	THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C.
RULE 17Ad-15.
# Council Implementing Regulation (EU) No 46/2014Show full title

Council Implementing Regulation (EU) No 46/2014 of 20 January 2014 implementing Regulation (EC) No 765/2006 concerning restrictive            measures in respect of Belarus         

        - Previous
        - Next

U.K.

# Council Implementing Regulation (EU) No 46/2014                     

# of 20 January 2014

# implementing Regulation (EC) No 765/2006 concerning restrictive measures in respect of Belarus

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EC) No 765/2006(1), and in particular Article 8a(1) and 8a(3) thereof,                        

Whereas:

(1)On 18 May 2006, the Council adopted Regulation (EC) No 765/2006.

(2)The Council considers that the reasons for the listing of one person as set out in Annex I to Regulation (EC) No 765/2006                              should be amended.

(3)Annex I to Regulation (EC) No 765/2006 should therefore be amended accordingly,

HAS ADOPTED THIS REGULATION:

# Article 1U.K.

Annex I to Regulation (EC) No 765/2006 is amended as set out in the Annex to this Regulation.

# Article 2U.K.

This Regulation shall enter into force on the day of its publication in the *Official Journal of the European Union.*                   

Done at Brussels, 20 January 2014.

*For the Council*                            

*The President*                            

C. Ashton                            

## ANNEXU.K.

In Annex I to Regulation (EC) No 765/2006, entry No. 210 shall be replaced by the following:

1

Council Regulation (EC) No 765/2006 of 18 May 2006 concerning restrictive measures in respect of Belarus (OJ L 134, 20.05.2006, p. 1).
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention 

          - [RFA AA169] 

                    A notice announcing the availability of Fiscal Year (FY) 2005 funds for a cooperative agreement for Building for Local Organizations in the Republic of South Africa and the Kingdoms of Lesotho and Swaziland, was published in the                     **Federal Register**                    , August 12, 2005, Volume 70, Number 155, pages 47209-47214.                 

This notice is amended as follows: 

Page 47210, Approximate Total Funding: delete $500,000, and replace with $5,000,000. Page 47210, Approximate Average Award, delete $100,000, and replace with $500,000-$1,000,000. Page 47210, Ceiling of Award Range, delete $100,000, and replace with $1,000,000. 

Dated: August 23, 2005. 

William P. Nichols, 

Director, Procurement and Grants Office, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.

[FR Doc. 05-17177 Filed 8-29-05; 8:45 am] 

BILLING CODE 4163-18-U
EXHIBIT 32



CERTIFICATIONS PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)



The undersigned officers of Active Power, Inc., a Delaware corporation (the
Company), do hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to their knowledge:



| |  | the Annual Report on Form 10-K/A of the Company for the year ended December 31, 2004, as filed with the Securities and Exchange Commission (the Report) fully complies
with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
|- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  | the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Joseph F. Pinkerton, IIIChairman of the Board, President and Chief Executive OfficerMarch 23, 2005/s/ David S. GinoDavid S. GinoVice President, Chief Operating Officer and Chief
Financial OfficerMarch 23, 2005




A signed original of this
written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
STATE v. Kenneth BARNARD.

No. 347A07.

Supreme Court of North Carolina.

February 13, 2008.

Daniel Johnson, Special Deputy Attorney General, Ronald L. Moore, District Attorney, for State of NC.

Isaac T. Avery, III, Raleigh, for NC Asso. of Police Attorneys.

Kimberly N. Overton, for NC Conference of DA.

The following order has been entered on the motion filed on the 12th day of February 2008 by Defendant to Deem Brief Timely Filed:

*4"Motion Allowed by order of the Court in conference this the 13th day of February 2008."
STATE v. Mario Lynn PHILLIPS.

No. 48A08.

Supreme Court of North Carolina.

May 16, 2008.

Maureen Krueger, Garland N. Yates, District Attorneys, for State of NC.

Anne Gomez, Assistant Appellate Defender, for Phillips.

The following order has been entered on the motion filed on the 14th day of May 2008 by Defendant for Extension of Time for Court Reporter to Prepare the Transcripts:

*667"Motion Allowed. Court reporter shall have up to and including the 19th day of June 2008 to prepare and deliver transcript to counsel. By order of the Court in conference this the 16th day of May 2008."
# Commission Implementing Regulation (EU) No 417/2013Show full title

Commission Implementing Regulation (EU) No 417/2013 of 6 May 2013 establishing the standard import values for determining            the entry price of certain fruit and vegetables         

        - Previous
        - Next

U.K.

# Commission Implementing Regulation (EU) No 417/2013                     

# of 6 May 2013

# establishing the standard import values for determining the entry price of certain fruit and vegetables

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EC) No 1234/2007 of 22 October 2007 establishing a common organisation of agricultural                           markets and on specific provisions for certain agricultural products (Single CMO Regulation)(1),                        

Having regard to Commission Implementing Regulation (EU) No 543/2011 of 7 June 2011 laying down detailed rules for the application                           of Council Regulation (EC) No 1234/2007 in respect of the fruit and vegetables and processed fruit and vegetables sectors(2), and in particular Article 136(1) thereof,                        

Whereas:

(1)Implementing Regulation (EU) No 543/2011 lays down, pursuant to the outcome of the Uruguay Round multilateral trade negotiations,                              the criteria whereby the Commission fixes the standard values for imports from third countries, in respect of the products                              and periods stipulated in Annex XVI, Part A thereto.

(2)The standard import value is calculated each working day, in accordance with Article 136(1) of Implementing Regulation (EU)                              No 543/2011, taking into account variable daily data. Therefore this Regulation should enter into force on the day of its                              publication in the *Official Journal of the European Union*,

HAS ADOPTED THIS REGULATION:

# Article 1U.K.

The standard import values referred to in Article 136 of Implementing Regulation (EU) No 543/2011 are fixed in the Annex to                     this Regulation.                  

# Article 2U.K.

This Regulation shall enter into force on the day of its publication in the *Official Journal of the European Union*.                  

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 6 May 2013.

*For the Commission, On behalf of the President*,                           

Jerzy Plewa                            

*Director-General for Agriculture and Rural Development*                            

## ANNEXU.K.Standard import values for determining the entry price of certain fruit and vegetables

1

OJ L 299, 16.11.2007, p. 1.                           

2

OJ L 157, 15.6.2011, p. 1.